These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10229198)

  • 1. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism.
    Sciacca L; Costantino A; Pandini G; Mineo R; Frasca F; Scalia P; Sbraccia P; Goldfine ID; Vigneri R; Belfiore A
    Oncogene; 1999 Apr; 18(15):2471-9. PubMed ID: 10229198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
    Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
    Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.
    Pandini G; Vigneri R; Costantino A; Frasca F; Ippolito A; Fujita-Yamaguchi Y; Siddle K; Goldfine ID; Belfiore A
    Clin Cancer Res; 1999 Jul; 5(7):1935-44. PubMed ID: 10430101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
    Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function.
    Singer C; Rasmussen A; Smith HS; Lippman ME; Lynch HT; Cullen KJ
    Cancer Res; 1995 Jun; 55(11):2448-54. PubMed ID: 7757999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
    Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
    Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer.
    Vella V; Pandini G; Sciacca L; Mineo R; Vigneri R; Pezzino V; Belfiore A
    J Clin Endocrinol Metab; 2002 Jan; 87(1):245-54. PubMed ID: 11788654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines.
    Serrano ML; Sánchez-Gómez M; Bravo MM; Yakar S; LeRoith D
    Horm Metab Res; 2008 Oct; 40(10):661-7. PubMed ID: 18711691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
    Webster NJ; Resnik JL; Reichart DB; Strauss B; Haas M; Seely BL
    Cancer Res; 1996 Jun; 56(12):2781-8. PubMed ID: 8665514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
    Huynh H; Chow PK; Ooi LL; Soo KC
    Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor II mRNA expression in human breast cancer.
    Yee D; Cullen KJ; Paik S; Perdue JF; Hampton B; Schwartz A; Lippman ME; Rosen N
    Cancer Res; 1988 Dec; 48(23):6691-6. PubMed ID: 3180080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between the oestrogen and insulin-like growth factor signalling pathways in the control of breast epithelial cell proliferation.
    Westley BR; Clayton SJ; Daws MR; Molloy CA; May FE
    Biochem Soc Symp; 1998; 63():35-44. PubMed ID: 9513709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
    Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
    Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
    Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding.
    Pandini G; Conte E; Medico E; Sciacca L; Vigneri R; Belfiore A
    Ann N Y Acad Sci; 2004 Dec; 1028():450-6. PubMed ID: 15650270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review.
    Denley A; Wallace JC; Cosgrove LJ; Forbes BE
    Horm Metab Res; 2003; 35(11-12):778-85. PubMed ID: 14710358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.